Report #2893833

Received Apr 23, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 55 yrs
State: —
Recovered: Recovered
Vaccinated: Mar 12, 2026
Onset: Mar 12, 2026
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (2)

AgeusiaDecreased appetite

Symptom narrative

loss of appetite; loss of taste; This non-serious case was reported by a physician via sales rep and described the occurrence of appetite lost in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 12-MAR-2026, the patient received Shingrix. On 12-MAR-2026, less than a day after receiving Shingrix, the patient experienced appetite lost (Verbatim: loss of appetite) and taste loss (Verbatim: loss of taste). On 15-MAR-2026, the outcome of the appetite lost and taste loss were resolved (duration 3 days). The reporter considered the appetite lost and taste loss to be related to Shingrix. The company considered the appetite lost and taste loss to be related to Shingrix. Additional Information: GSK Receipt Date: 16-APR-2026 The patient had a subsequent dose of vaccine. The patient reported that she had loss of taste and appetite. The batch number was not provided and a request for this information has been made.